{"id":58657,"date":"2024-01-02T16:06:12","date_gmt":"2024-01-02T15:06:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/"},"modified":"2024-01-02T16:06:12","modified_gmt":"2024-01-02T15:06:12","slug":"sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/","title":{"rendered":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values"},"content":{"rendered":"
\n

\nIssuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart rate (HR) measurements from electrocardiogram (ECG)-based sensors<\/i><\/p>\n

DETROIT–(BUSINESS WIRE)–Sports Data Labs, Inc. (\u201cSD Labs\u201d), an award-winning leader in AI-based collection, analysis, and distribution of real-time human data from on-body sensors and other sensing systems, announced today that the United States Patent and Trademark Office (\u201cUSPTO\u201d) has issued U.S. Patent No. 11,850,053 to the company covering a novel system and method for calculating accurate, real-time heart rate (HR) measurements from high sampling, electrocardiogram (ECG)-based sensors. SD Labs\u2019 issued patent, entitled \u201cA System and Method for Measuring Heart Rate,\u201d also covers a novel method for detecting and replacing missing and outlier sensor-based data values with artificial (i.e., synthetic) data.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nThe issued patent leverages novel techniques to denoise raw sensor data derived from any sensors that produce digital readings where R-peaks can be identified to generate accurate, real-time heart rate readings that are particularly advantageous for physically-active bodies (e.g., professional athletes in live events) in non-laboratory, real-world settings. The novel denoising techniques were part of a peer-review validation study featured in the biomedical journal Digital Biomarkers <\/i>entitled \u201cReal-time Digital Biometric Monitoring During Elite Athletic Competition: System Feasibility with a Wearable Medical-Grade Sensor<\/a>\u201d that demonstrated \u2013 for the first time \u2013 repeatable and accurate collection and display of real-time heart rate measurements from wearable medical-grade sensors in live professional sports competition.<\/p>\n

\nThe issued patent also covers an AI-based method for generating predictive artificial data values for any missing or outlier values within a sensor-based data set, which can be applicable to all types of biological sensor data regardless of sensor type. With the USPTO\u2019s Patent Term Adjustment, the issued patent will provide SD Labs with exclusivity for its invention in the U.S. until March 2041.<\/p>\n

\n\u201cWe are thrilled with the issuance of this foundational patent in the generative AI space,\u201d said Vivek Khare, Co-Inventor and Head of Technology of SD Labs, the assignee of U.S. Patent No. 11,850,053. \u201cOur synthetic data generator enables more complete data sets to be created, a requisite for AI systems to be more effective in analyzing and creating value with data. Our exclusivity in key areas related to ECG-based real-time heart monitoring and synthetic data generation will allow us to dive further into exciting licensing and solution-focused opportunities in sports, healthcare, insurance, and other high-growth markets.\u201d<\/p>\n

\n\u201cWe were very early in leveraging generative AI techniques to support our work with medical-grade sensors,\u201d said Mark Gorski, Co-Inventor and CEO, SD Labs. \u201cWith our patented SaaS-Based Health Diagnostics and Sensor Interoperability System<\/a>, patented Health Drone<\/a>, and other patent-pending technologies tied to collection, consent, and monetization of sensor-based data, we believe our category-defining patent portfolio will continue to be at the epicenter of value creation in the personal data ecosystem.\u201d<\/p>\n

\nThe patented system also covers the provision of one or more recommendations to take one or more actions based on the derived heart rate values. For example, if the heart rate measurements are irregular, the patented system can be configured to provide an alert such as \u201cstop your activity\u201d or \u201csee a doctor.\u201d<\/p>\n

\nWith thirteen active patent families, this is the company\u2019s fourth issued U.S. Patent.<\/p>\n

\nAbout Sports Data Labs, Inc.<\/b><\/p>\n

\nSports Data Labs, Inc. (SD Labs) is a venture-backed, award-winning leader in AI-based collection, analysis and distribution of real-time human data from on-body sensors and sensing systems, as well as other data sources. SD Labs provides patented and other proprietary technologies that empower individuals to collect, control, and distribute their personal data, while using artificial intelligence to transform collected data into metrics, insights and predictions for various real-time and on-demand use cases. SD Labs also provides data acquisition and monetization solutions for buyers and sellers of personal data through its proprietary Human Data Marketplace. For more information, please visit www.sportsdatalabs.com<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nSD Labs Corporate Communications
\n
pr@sportsdatalabs.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart rate (HR) measurements from electrocardiogram (ECG)-based sensors DETROIT–(BUSINESS WIRE)–Sports Data Labs, Inc. (\u201cSD Labs\u201d), an award-winning leader in AI-based collection, analysis, and distribution of real-time human data from on-body sensors and other sensing systems, announced today that … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58657","6":"format-standard","7":"category-industry"},"yoast_head":"\nSports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart rate (HR) measurements from electrocardiogram (ECG)-based sensors DETROIT–(BUSINESS WIRE)–Sports Data Labs, Inc. (\u201cSD Labs\u201d), an award-winning leader in AI-based collection, analysis, and distribution of real-time human data from on-body sensors and other sensing systems, announced today that ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-02T15:06:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values\",\"datePublished\":\"2024-01-02T15:06:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240102111700\\\/en\\\/1985054\\\/21\\\/Sports_Data_Labs_Cover_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/\",\"name\":\"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240102111700\\\/en\\\/1985054\\\/21\\\/Sports_Data_Labs_Cover_1.jpg\",\"datePublished\":\"2024-01-02T15:06:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240102111700\\\/en\\\/1985054\\\/21\\\/Sports_Data_Labs_Cover_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240102111700\\\/en\\\/1985054\\\/21\\\/Sports_Data_Labs_Cover_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/","og_locale":"en_US","og_type":"article","og_title":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend","og_description":"Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart rate (HR) measurements from electrocardiogram (ECG)-based sensors DETROIT–(BUSINESS WIRE)–Sports Data Labs, Inc. (\u201cSD Labs\u201d), an award-winning leader in AI-based collection, analysis, and distribution of real-time human data from on-body sensors and other sensing systems, announced today that ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/","og_site_name":"Pharma Trend","article_published_time":"2024-01-02T15:06:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values","datePublished":"2024-01-02T15:06:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/"},"wordCount":682,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/","url":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/","name":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg","datePublished":"2024-01-02T15:06:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240102111700\/en\/1985054\/21\/Sports_Data_Labs_Cover_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sports-data-labs-inc-announces-issuance-of-new-u-s-patent-covering-its-novel-generative-ai-based-method-for-creating-synthetic-data-to-replace-missing-and-outlier-data-values\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sports Data Labs, Inc. Announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58657"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58657\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}